Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

12.05
Delayed Data
As of May 26
 +0.15 / +1.26%
Today’s Change
4.10
Today|||52-Week Range
15.05
+159.14%
Year-to-Date
5 Stocks Setting Up for Big Breakouts
May 26 / TheStreet.com - Paid Partner Content
TG Therapeutics Stock Climbs After Successfully Completed Analysis in UNITY-CLL
May 23 / TheStreet.com - Paid Partner Content
The Machines Are Sapping the Fun out of This Day
May 26 / TheStreet.com - Paid Partner Content
Shark Bites: There Wasn't Even a Dip to Buy
May 23 / TheStreet.com - Paid Partner Content
Biotech Needs a Shot in the Arm
May 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close11.90
Today’s open11.90
Day’s range11.80 - 12.55
Volume1,266,542
Average volume (3 months)1,893,501
Market cap$804.6M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-15.94%
Earnings growth (this year)-7.08%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,496.53
Price/Book19.08

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.29-6.79%
ALDRAlder Biopharmaceuti...-0.90-5.28%
BHVNBiohaven Pharmaceuti...+0.82+3.57%
SGYPSynergy Pharmaceutic...-0.21-5.69%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$152.4K
Annual profit (last year)-$78.3M
Net profit margin-51,353.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts